An in vitro and in vivo study of combination therapy with Photogem®-mediated photodynamic therapy and cisplatin on mouse cancer cells (CT-26)

Photomedicine and Laser Surgery

Volumn 29, Issue 3, 2011, Pages 155-160

  Ge, Ruifeng ^a,b   Ahn, Jin Chul ^a   Shin, Jang In ^a   Bahk, Chan Woong ^a   He, Peijie ^a   Chung, Phil Sang ^a  

^a Dankook University   (South Korea)

^b QINGDAO MUNICIPAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICANCER EFFECTS; CANCER CELLS; CELL VIABILITY; CHEMOTHERAPEUTIC AGENTS; CIS-PLATIN; COLON CANCER CELLS; COMBINATION THERAPY; COMBINED THERAPY; DIODE LASERS; ENERGY DENSITY; IN-VITRO; IN-VIVO; MTT ASSAYS; PHOTOGEM;

CELLS; DISEASES; OPTIMIZATION; PLASMONS; PLATINUM COMPOUNDS; TUMORS;

PHOTODYNAMIC THERAPY;

ANTINEOPLASTIC AGENT; CISPLATIN;

ANALYSIS OF VARIANCE; ANIMAL; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; COLON TUMOR; COMPARATIVE STUDY; DIODE LASER; DISEASE MODEL; DRUG EFFECT; FEMALE; IN VITRO STUDY; INSTRUMENTATION; LOW LEVEL LASER THERAPY; METHODOLOGY; MOUSE; MULTIMODALITY CANCER THERAPY; PHOTOCHEMOTHERAPY; RANDOMIZATION; REFERENCE VALUE; SKIN ABSORPTION; SPECTROSCOPY; TREATMENT OUTCOME; TUMOR CELL CULTURE;

ANALYSIS OF VARIANCE; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CISPLATIN; COLONIC NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE MODELS, ANIMAL; FEMALE; LASER THERAPY, LOW-LEVEL; LASERS, SEMICONDUCTOR; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; PHOTOCHEMOTHERAPY; RANDOM ALLOCATION; REFERENCE VALUES; SKIN ABSORPTION; SPECTRUM ANALYSIS; TREATMENT OUTCOME; TUMOR CELLS, CULTURED;

EID: 79952418335     PISSN: 15495418     EISSN: None     Source Type: Journal    
DOI: 10.1089/pho.2009.2750     Document Type: Article

References (28)

1. Wilson, B. C. (2002). Photodynamic therapy for cancer: principles. Can. J. Gastroenterol. 16, 393-396.
2. Rechtman, E., Ciulla, T. A., Criswell, M. H., Pollack, A., and Harris, A. (2002). An update on photodynamic therapy in age-related macular degeneration. Expert Opin. Pharmacother. 3, 931-938. (Pubitemid 34752510)
3. Gomer, C. J., and Dougherty, T. J. (1979). Determination of [3H]-and [14C] hematoporphyrin derivative distribution in malignant and normal tissue. Cancer Res. 39, 146-151. (Pubitemid 9090426)
4. Dougherty, T. J., Gomer, C. J., Henderson, B. W., et al. (1998). Photodynamic therapy. J. Natl. Cancer Inst. 90, 889-905. (Pubitemid 28304157)
5. Wyld, L., Reed, M. W., and Brown, N. J. (2001). Differential cell death response to photodynamic therapy is dependent on dose and cell type. Br. J. Cancer. 84, 1384-1386. (Pubitemid 32522108)
6. Meyer, K. B., and Madias, N. E. (1994). Cisplatin nephrotoxicity. Miner. Electrolyte Metab. 20, 201-213. (Pubitemid 24320004)
7. Schwerdt, G., Freudinger, R., Schuster, C., Silbernagl, S., and Gekle, M. (2003). Inhibition of mitochondria prevents cell death in kidney epithelial cells by intra-and extracellular acidification. Kidney Int. 63, 1725-1735. (Pubitemid 36513318)
8. Crul, M., van Waardenburg, R. C., Beijnen, J. H., and Schellens, J. H. (2002). DNA-based drug interactions of cisplatin. Cancer Treat. Rev. 28, 291-303. (Pubitemid 36054538)
9. Nonaka, M., Ikeda, H., and Inokuchi, T. (2002). Effect of combined photodynamic and chemotherapeutic treatment on lymphoma cells in vitro. Cancer Lett. 184, 171-178. (Pubitemid 34808714)
10. Crescenzi, E., Varriale, L., Iovino, M., Chiaviello, A., Veneziani, B. M., and Palumbo, G. (2004). Photodynamic therapy with indocyanine green complements and enhances lowdose cisplatin cytotoxicity in MCF-7 breast cancer cells. Mol. Cancer Ther. 3, 537-544. (Pubitemid 39193732)
11. Niu, M. Y. (1992). Effect of combined use of chemotherapeutic agents and hematoporphyrin derivative (HPD) on human gastric cancer cell line in vitro. Zhonghua Zhong Liu Za Zhi. 14, 70-72.
12. Cowled, P. A., Mackenzie, L., and Forbes, I. J. (1987). Pharmacological modulation of photodynamic therapy with hematoporphyrin derivative and light. Cancer Res. 47, 971-974. (Pubitemid 17027912)
13. Uehara, M., Inokuchi, T., and Ikeda, H. (2006). Enhanced susceptibility of mouse squamous cell carcinoma to photodynamic therapy combined with low-dose administration of cisplatin. J. Oral Maxillofac. Surg. 64, 390-396. (Pubitemid 43257922)
14. Canti, G., Nicolin, A., Cubeddu, R., Taroni, P., Bandieramonte, G., and Valentini, G. (1998). Antitumor efficacy of the combination of photodynamic therapy and chemotherapy in murine tumors. Cancer Lett. 125, 39-44. (Pubitemid 28151907)
15. Chu, G. (1994). Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair. J. Biol. Chem. 269, 787-790.
16. Piette, J., Volanti, C., Vantieghem, A., Matroule, J. Y., Habraken, Y., and Agostinis, P. (2003). Cell death and growth arrest in response to photodynamic therapy with membrane-bound photosensitizers. Biochem. Pharmacol. 66, 1651-1659. (Pubitemid 38373358)
17. Herr, I., Wilhelm, D., Bohler, T., Angel, P., and Debatin, K. M. (1997). Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis. EMBO J. 16, 6200-6208. (Pubitemid 27458340)
18. Kessel, D., Luo, Y., Deng, Y., and Chang, C. K. (1997). The role of subcellular localization in initiation of apoptosis by photodynamic therapy. Photochem. Photobiol. 65, 422-426. (Pubitemid 27158974)
19. Tacka, K. A., Dabrowiak, J. C., Goodisman, J., Penefsky, H. S., and Souid, A. K. (2004). Effects of cisplatin on mitochondrial function in Jurkat cells. Chem. Res. Toxicol. 17, 1102-1111. (Pubitemid 39108678)
20. Douple, E. B. and Richmond, R. C. (1978). Platinum complexes as radiosensitizers of hypoxic mammalian cells. Br. J. Cancer Suppl. 3, 98-102. (Pubitemid 8364461)
21. Fu, K. K., De Gregorio, M. W., and Phillips, J. W. (1988). Plasma and tumor concentrations of cisplatin following intraperitoneal infusion or bolus injection with or without continuous low-dose-rate irradiation. NCI Monogr. 123-127. (Pubitemid 18047975)
22. Lagrange, J. L., Bondiau, P. Y., Tessier, E., et al. (1996). Tumoral platinum concentrations in patients treated with repeated low-dose cisplatin as a radiosensitizer. Int. J. Cancer. 68, 452-456. (Pubitemid 26414499)
23. Oswald, C. B., and Hall, I. H. (1989). The inhibition of P338 lymphocytic leukemia DNA polymerase alpha activity by cis-diamminedichloroplatinum (II) and related derivatives. Anticancer Res. 9, 915-922. (Pubitemid 19266328)
24. Ahn, W. S., Bae, S. M., Huh S. W., et al. (2004). Necrosis-like death with plasma membrane damage against cervical cells by photodynamic therapy. Int. J. Gynecol Center. 14, 475-482. (Pubitemid 38747428)
25. Nahabedian, M. Y., Cohen, R. A., Contino, M. F., et al. (1988). Combination cytotoxic chemotherapy with cisplatin or doxorubicin and photodynamic therapy in murine tumors. J. Natl. Cancer Inst. 80, 739-743.
26. Kosharskyy, B., Solban, N., Chang, S. K., Rizvi, I., Chang, Y., and Hasan, T. (2006). A mechanism-based combination therapy reduces local tumor growth and metastasis in an orthotopic model of prostate cancer. Cancer Res. 66, 10953-10958. (Pubitemid 44876994)
27. Nakajima, S., Sakata, I., Hirano, T., and Takemura, T. (1998). Therapeutic effect of interstitial photodynamic therapy using ATX-S10 (Na) and a diode laser on radio-resistant SCCVII tumors of C3H/He mice. Anticancer Drugs. 9, 539-543. (Pubitemid 28346503)
28. Mori, M., Sakata, I., Hirano, T., Obana, A., Nakajima, S., Hikida, M., and Kumagai, T. (2000). Photodynamic therapy ofr experimental tumors using ATX-S10 (Na), a hydrophilic chlorine photosensitizer, and diode laser. Jpn J Cancer Res. 91, 753-759. (Pubitemid 30612361)